Loretelli et al., 2021 - Google Patents
The IL-8-CXCR1/2 axis contributes to diabetic kidney diseaseLoretelli et al., 2021
View PDF- Document ID
- 9747080556681603323
- Author
- Loretelli C
- Rocchio F
- D'Addio F
- Nasr M
- Castillo-Leon E
- Dellepiane S
- Vergani A
- Abdelsalam A
- Assi E
- Maestroni A
- Usuelli V
- Bassi R
- Pastore I
- Yang J
- El Essawy B
- Elased K
- Fadini G
- Ippolito E
- Seelam A
- Pezzolesi M
- Corradi D
- Zuccotti G
- Gallieni M
- Allegretti M
- Niewczas M
- Fiorina P
- Publication year
- Publication venue
- Metabolism
External Links
Snippet
Aims/hypothesis Inflammation has a major role in diabetic kidney disease. We thus investigated the role of the IL-8-CXCR1/2 axis in favoring kidney damage in diabetes. Methods Urinary IL-8 levels were measured in 1247 patients of the Joslin Kidney Study in …
- 208000007342 Diabetic Nephropathy 0 title abstract description 84
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Loretelli et al. | The IL-8-CXCR1/2 axis contributes to diabetic kidney disease | |
| Lavoz et al. | Interleukin-17A blockade reduces albuminuria and kidney injury in an accelerated model of diabetic nephropathy | |
| Xu et al. | Emodin alleviates severe acute pancreatitis-associated acute lung injury by inhibiting the cold-inducible RNA-binding protein (CIRP)-mediated activation of the NLRP3/IL-1 β/CXCL1 signaling | |
| Villapol et al. | Neurorestoration after traumatic brain injury through angiotensin II receptor blockage | |
| Feng et al. | PCSK9 causes inflammation and cGAS/STING pathway activation in diabetic nephropathy | |
| Ho et al. | Egr-1 deficiency protects from renal inflammation and fibrosis | |
| Zhao et al. | Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration | |
| Tan et al. | Combination therapy with paricalcitol and trandolapril reduces renal fibrosis in obstructive nephropathy | |
| Ma et al. | Interleukin-37 protects against acinar cell pyroptosis in acute pancreatitis | |
| Zychowska et al. | Spinal CCL1/CCR8 signaling interplay as a potential therapeutic target–evidence from a mouse diabetic neuropathy model | |
| US20070015796A1 (en) | Compositions and methods for treatment of fibrosis | |
| Zhu et al. | Deletion of macrophage migration inhibitory factor ameliorates inflammation in mice model severe acute pancreatitis | |
| Zhang et al. | Transforming growth factor‐β1 mediates psoriasis‐like lesions via a Smad3‐dependent mechanism in mice | |
| Fu et al. | The mechanosensitive ion channel Piezo1 contributes to podocyte cytoskeleton remodeling and development of proteinuria in lupus nephritis | |
| KR20150131260A (en) | Methods of treating colorectal cancer | |
| Xu et al. | TIMP2 protects against sepsis-associated acute kidney injury by cAMP/NLRP3 axis-mediated pyroptosis | |
| Cui et al. | Endothelial CXCR2 deficiency attenuates renal inflammation and glycocalyx shedding through NF-κB signaling in diabetic kidney disease | |
| Xiang et al. | Tiamulin inhibits TNF-α and alleviates psoriasis-like dermatitis | |
| Wang et al. | Targeting inflammation and necroptosis in diabetic kidney disease: A novel approach via PPARα modulation | |
| Yu et al. | Mesencephalic astrocyte-derived neurotrophic factor ameliorates inflammatory response in polycystic ovary syndrome via inhibiting TLR4-NF-κB-NLRP3 pathway | |
| Wang et al. | α-amanitin induces hepatotoxicity via PPAR-γ inhibition and NLRP3 inflammasome activation | |
| Gao et al. | Interferon regulatory factor 4 deletion protects against kidney inflammation and fibrosis in deoxycorticosterone acetate/salt hypertension | |
| Zhou et al. | USP10-mediated deubiquitination of NR3C1 regulates bone homeostasis by controlling CST3 expression | |
| Zhao et al. | Mineralocorticoid promotes intestinal inflammation through receptor dependent IL17 production in ILC3s | |
| Zhang et al. | Inhibition of (pro) renin receptor contributes to renoprotective effects of angiotensin II type 1 receptor blockade in diabetic nephropathy |